ArticleInternal medicine (Tokyo, Japan)2022

Graves' Disease after Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine in a Type 1 Diabetes Patient.

Mayu Sakai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.